Selective Estrogen Receptor Modulators Enhance CNS Remyelination Independent of Estrogen Receptors

A significant unmet need for patients with multiple sclerosis (MS) is the lack of U.S. Food and Drug Administration (FDA)-approved remyelinating therapies. We have identified a compelling remyelinating agent, bazedoxifene (BZA), a European Medicines Agency (EMA)-approved (and FDA-approved in combina...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Neurosci
Egile Nagusiak: Rankin, Kelsey A., Mei, Feng, Kim, Kicheol, Shen, Yun-An A., Mayoral, Sonia R., Desponts, Caroline, Lorrain, Daniel S., Green, Ari J., Baranzini, Sergio E., Chan, Jonah R., Bove, Riley
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Society for Neuroscience 2019
Gaiak:
Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6433770/
https://ncbi.nlm.nih.gov/pubmed/30696729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.1530-18.2019
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak